Minerva Neurosciences
Minerva Neurosciences is a leading biotech company based in Waltham, MA, specializing in the development of innovative treatments for central nervous system disorders. With a strong focus on clinical development, their expertise lies in designing trials with patient-centric endpoints, aiming to provide direct benefits to individuals suffering from conditions such as schizophrenia and Parkinson's disease.
Driven by a commitment to innovation, Minerva Neurosciences boasts an impressive pipeline of product candidates, including Roluperidone, MIN-101, MIN-301, and Seltorexant. By leveraging their clinical expertise and patient-focused approach, they strive to improve the lives of those affected by neurological disorders, making significant contributions to the field of neuroscience.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.

